About Quinta Analytica
Quinta Analytica is a Healthcare company based in Prague (Czechia) founded in 1997, and was acquired by Genesis Capital in June 2016. Bioanalytical and regulatory support services are provided for drug industries. Quinta Analytica offers products and services including Analytical R&D, Pharmaceutical Analyses, Biologics Analysis, Bioanalytical Testing, and Clinical Testing. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is QUINTA-ANALYTICA s.r.o.
Company details
Quinta Analytica was established in 1997 in Prague, Czech Republic. Services are extended to pharmaceutical, biotechnology, and generic drug sectors, encompassing pharmacokinetics, BABE clinical studies, drug analysis through method development and transfer, cGMP testing of APIs, FDFs, and metabolites, batch QC release, stability studies, inhalation antiasthmatic analytics, and peptideprotein evaluations. FDA audits have been completed, with GCPGLPGMP certifications maintained.
- Headquarters Prague, Czechia
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website quinta.cz
- Social LinkedIn Facebook YouTube
- Acquired by Genesis Capital (Jun 2016)
- Legal Name Quinta-Analytica S.R.O.
- Investors
- Acquired byGenesis Capital
(Jun 2016)
Products & Services of Quinta Analytica
Quinta Analytica offers a comprehensive portfolio of products and services, including Analytical R&D, Pharmaceutical Analyses, Biologics Analysis, Bioanalytical Testing, and Clinical Testing.
Development of analytical methods and degradation studies for pharmaceuticals.
Validation of methods and quality control for pharmaceutical products.
Analytical services for large molecules in pharmaceutical applications.
Pre-clinical to Phase III testing with statistical evaluation.
Conducts BA/BE/PK studies in dedicated clinical units.
Apps and channels of Quinta Analytica
its YouTube channel Quinta - Analytica has 35 subscribers and 12 videos.
Videos from Quinta Analytica
The most watched videos on Quinta Analytica's YouTube channel, Quinta - Analytica (35 subscribers). Click a video to play it here.
More on Quinta - Analytica.
Investors in Quinta Analytica
Quinta Analytica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Genesis Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Genesis Capital is engaged in providing financial advisory services. | genesis-capital.com | Atlanta, USA |
Investor details for Quinta Analytica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Quinta Analytica
15 people are tracked at Quinta Analytica (7 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Olga Pichlová | Head Of Clinical Department | Leadership |
Katerina Bilkova | Head Of Clinic | Leadership |
Matej Sepeši | Deputy Head Of Gc/icp Laboratory | Leadership |
Roman Grunt | CEO | Leadership |
Lia Martinez-Montero | Director Of Business Development | Leadership |
Milan Madera | Head Of QC Division | Leadership |
Jiri Raska | Chief Commercial Officer | Leadership |
Martina Matiskova | Research And Development Analyst | Team |
Barbora Skalníková | Analytical Chemist | Team |
Zdenek Panek | Business Manager | Team |
Jan Prell | Pharmacokineticist And Biostatistician | Team |
Pavel Berka | HPLC Analyst In Highly Potent Substances Laboratory (hpsl) | Team |
Milan Libansky | Marketing Specialist Specializing In The Pharmaceutical Industry | Team |
Jan Chalupa | Vedoucí Validačního Týmu | Team |
Gabriela Manai | Assistant Of Management | Team |
Complete people profiles for Quinta Analytica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Quinta Analytica
2 dated milestones of Quinta Analytica across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Quinta Analytica is founded.
- Exit Acquired by Genesis Capital.
Web traffic of Quinta Analytica
The website of Quinta Analytica (quinta.cz) receives about 3.1K visits a month.
- Monthly visits3.1K
▼ 7.4% vs previous month
Websites whose visitors overlap most with Quinta Analytica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| centerwatch.com | 100% | 158.2K | #254,725 | View details | |
diahome.org | diahome.org | 96% | – | ||
cato.com | cato.com | 69% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Quinta Analytica
Quinta Analytica was founded in 1997.
Quinta Analytica is headquartered in Prague, Czechia.
Quinta Analytica was established in 1997 in Prague, Czech Republic. Services are extended to pharmaceutical, biotechnology, and generic drug sectors, encompassing pharmacokinetics, BABE clinical studies, drug analysis through method development and transfer, cGMP testing of APIs, FDFs, and metabolites, batch QC release, stability studies, inhalation antiasthmatic analytics, and peptideprotein evaluations. FDA audits have been completed, with GCPGLPGMP certifications maintained.
Quinta Analytica offers Analytical R&D, Pharmaceutical Analyses, Biologics Analysis, Bioanalytical Testing, and Clinical Testing.
Quinta Analytica has 1 investor. Key investors include Genesis Capital.
Quinta Analytica operates through Quinta-Analytica S.R.O..
Yes. Quinta Analytica was acquired by Genesis Capital in June 2016.